HU0302028D0 - Process for the production of crystalline polymorphous form of an anticoagulant agent - Google Patents
Process for the production of crystalline polymorphous form of an anticoagulant agentInfo
- Publication number
- HU0302028D0 HU0302028D0 HU0302028A HUP0302028A HU0302028D0 HU 0302028 D0 HU0302028 D0 HU 0302028D0 HU 0302028 A HU0302028 A HU 0302028A HU P0302028 A HUP0302028 A HU P0302028A HU 0302028 D0 HU0302028 D0 HU 0302028D0
- Authority
- HU
- Hungary
- Prior art keywords
- production
- anticoagulant agent
- polymorphous form
- crystalline polymorphous
- crystalline
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229940127090 anticoagulant agent Drugs 0.000 title 1
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0302028A HU0302028D0 (en) | 2003-07-02 | 2003-07-02 | Process for the production of crystalline polymorphous form of an anticoagulant agent |
AT04743729T ATE461201T1 (en) | 2003-07-02 | 2004-06-30 | PROCESS FOR PRODUCING A CRYSTALLINE POLYMORPH OF A PLATELE AGGREGATION-INHIBITING MEDICINAL |
CZ20060041A CZ200641A3 (en) | 2003-07-02 | 2004-06-30 | Process for preparing crystalline polymorph of blood platelet coagulation inhibitor |
EA200600138A EA010684B1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
PL04743729T PL1644381T3 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
US10/563,133 US20070142637A1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
KR1020067000012A KR101155679B1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
EP04743729A EP1644381B1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
PCT/HU2004/000070 WO2005003139A1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
JP2006516497A JP4681545B2 (en) | 2003-07-02 | 2004-06-30 | Method for producing crystalline polymorphs of platelet aggregation inhibitors |
CN2004800181228A CN1812993B (en) | 2003-07-02 | 2004-06-30 | Process for preparing crystalline polymorph of blood platelet coagulation inhibitor |
UAA200600917A UA86772C2 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate |
CA2530449A CA2530449C (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
SK5010-2006A SK50102006A3 (en) | 2003-07-02 | 2004-06-30 | Method for the preparation of a polymorph of platelet aggregation inhibitor |
DE602004026059T DE602004026059D1 (en) | 2003-07-02 | 2004-06-30 | PROCESS FOR THE PREPARATION OF A CRYSTALLINE POLYMORPHIDE OF A PLAIN AGGREGATION-RESISTANT MEDICAMENT |
PL378710A PL378710A1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
BG109429A BG109429A (en) | 2003-07-02 | 2006-02-02 | Process for thre preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0302028A HU0302028D0 (en) | 2003-07-02 | 2003-07-02 | Process for the production of crystalline polymorphous form of an anticoagulant agent |
Publications (1)
Publication Number | Publication Date |
---|---|
HU0302028D0 true HU0302028D0 (en) | 2003-09-29 |
Family
ID=89981476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302028A HU0302028D0 (en) | 2003-07-02 | 2003-07-02 | Process for the production of crystalline polymorphous form of an anticoagulant agent |
Country Status (2)
Country | Link |
---|---|
HU (1) | HU0302028D0 (en) |
UA (1) | UA86772C2 (en) |
-
2003
- 2003-07-02 HU HU0302028A patent/HU0302028D0/en unknown
-
2004
- 2004-06-30 UA UAA200600917A patent/UA86772C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
UA86772C2 (en) | 2009-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173456A0 (en) | Process for the preparation of 4-amino-3-quinolinecarbonitriles | |
IL205419A0 (en) | Process for producing thiazole derivative | |
HK1079771A1 (en) | Process for the manufacture of valsartan | |
IL176472A0 (en) | Process for the preparation of pyridine derivatives | |
IL162817A0 (en) | Process for the manufacture of organic compounds | |
GB0316546D0 (en) | Process for the manufacture of organic compounds | |
GB0204129D0 (en) | Process for the manufacture of organic compounds | |
IL175743A0 (en) | Process for the preparation of thiazolopyrimidines | |
HK1096398A1 (en) | Method for the manufacture of thip thip | |
GB0210234D0 (en) | Process for the manufacture of organic compounds | |
MY143519A (en) | Process for the production of ethers | |
HUP0600231A2 (en) | Novel process for the preparation of 2h-chromenes | |
TWI319391B (en) | Process for the production of 3-methylthiopropanal | |
HK1095145A1 (en) | Process for the preparation of n-arylmorpholinones n- | |
EP1683776A4 (en) | Process for producing radioactive-fluorine-labeled compound | |
HU0302028D0 (en) | Process for the production of crystalline polymorphous form of an anticoagulant agent | |
HU0401272D0 (en) | Process for the production of crystalline polymorphous form of an anticoagulant agent | |
EP1659167A4 (en) | Process for producing monoglyceride-containing composition | |
PL1698619T3 (en) | Process for producing 2-halogenobenzamide compound | |
HK1087111A1 (en) | Process for the preparation of nicotinaldehydes | |
IL170747A0 (en) | Process for the production of imidazopyridin-8-one derivatives | |
HU0300255D0 (en) | Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine | |
EP1594877A4 (en) | Process for the production of 2-oxa-3-one androstane derivatives | |
GB0311836D0 (en) | Process for the manufacture of organic compounds | |
HU0401269D0 (en) | Process for the production of amorphous form of an antiagulant agent |